Activation of Cannabinoid Receptor 2 Prevents Colitis-Associated Colon Cancer in Mice

Inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis are caused by unrestrained inflammation of the gastrointestinal tract. Patients with IBD are at a higher risk of developing colorectal cancer. In a recent study published in iScience by authors from the University of South Carolina, it was shownRead …

Read moreActivation of Cannabinoid Receptor 2 Prevents Colitis-Associated Colon Cancer in Mice

Systematic Review and Meta-analysis: Cannabinoids in the Management of Acute Pain

acute pain

A new systematic review and meta-analysis showed a small but significant reduction in subjective pain scores for cannabinoid treatment compared to placebo in patients experiencing acute pain. No increase in serious adverse events suggested the safety of using cannabinoids to treat acute pain, according to the study published in CannabisRead …

Read moreSystematic Review and Meta-analysis: Cannabinoids in the Management of Acute Pain

Free Webinar: The Endocannabinoid System: Therapeutic Impact of Hemp and Full-spectrum Cannabinoids.

Therapeutic Impact of Hemp with Dr. Alex Capano

Healthcare professionals often have a knowledge gap when it comes to navigating the nascent hemp industry and providing evidence-based counseling to their communities. This webinar, Endocannabinoid System: Therapeutic Impact of Hemp and Full-spectrum Cannabinoids with Alex Capano, PhD, NP, BSN, MSN will cover the therapeutic potential and current scientific evidenceRead …

Read moreFree Webinar: The Endocannabinoid System: Therapeutic Impact of Hemp and Full-spectrum Cannabinoids.

Webinar: The Most Common Therapeutic Applications of CBD

CBD for Obsessive Compulsive Disorder

Do you have questions about the therapeutic applications of CBD? We thought so. Preclinical and clinical studies suggest that cannabidiol (CBD) has broad therapeutic value. With emerging knowledge and a lack of education about the Endocannabinoid System (ECS) in most medical schools, the vast majority of health professionals have limitedRead …

Read moreWebinar: The Most Common Therapeutic Applications of CBD

FDA Announces Early Fall Cannabidiol Hearings and Clarifies Commitment to Enforcement

cannabidiol hearings

The FDA announced that it will host further cannabidiol hearing on the regulatory structure of CBD products in the early fall. The news was embedded in a press release regarding a warning issued to a CBD maker CuraLeaf for making unfounded claims to treat cancer, Alzheimer’s disease, opioid withdrawal, painRead …

Read moreFDA Announces Early Fall Cannabidiol Hearings and Clarifies Commitment to Enforcement

Medicinal Cannabis Reduces or Ends Seizures in Children with Severe, Drug-resistant Epilepsy

drug-resistant epilepsy

Medicinal cannabis oil containing both cannabidiol (CBD) and a small amount of THC can reduce or end seizures in children with severe, drug-resistant epilepsy, a study by the University of Saskatchewan (USask), Canada has found. Children with severe drug-resistant epilepsy also experienced improvements in their quality of life after takingRead …

Read moreMedicinal Cannabis Reduces or Ends Seizures in Children with Severe, Drug-resistant Epilepsy

Could the Endocannabinoid System Offer a New Treatment Target for Obsessive Compulsive Disorder?

CBD for Obsessive Compulsive Disorder

The disabling condition of obsessive-compulsive disorder (OCD) affects about 2–3% of people worldwide. Evidence suggests that abnormalities in cortico-striatal-thalamic-cortical circuitry and specific gene variants contribute to the pathogenesis of the disorder. This latest study, published in Cannabis and Cannabinoid Research, suggests that the endocannabinoid system (ECS) plays a role in OCD symptomsRead …

Read moreCould the Endocannabinoid System Offer a New Treatment Target for Obsessive Compulsive Disorder?